Spermidine attenuates the inhibitory effect of ethanol on NMDA-induced neurotoxicity.
The exact site(s) and the molecular mechanism(s) by which ethanol inhibits the activity of NMDA receptors in the brain have so far not been identified although the involvement of several NMDA receptor modulatory sites activated by glycine, Mg2+, Zn2+, polyamines and red-ox agents has been suggested. In this study we investigated the effects of spermidine, a polyamine site agonist, on NMDA-induced neurotoxicity and its ability to modulate the inhibitory action of ethanol on neurotoxicity produced by the maximal neurotoxic concentration of NMDA as measured by the MTT assay in rat cerebellar granule cells. This assay measures the enzymatic activity in mitochondria and/or endosome/lysosome compartment that closely correlates with the cell viability. Spermidine dramatically potentiated NMDA-induced responses both at nontoxic and maximally neurotoxic NMDA concentrations. Ethanol, as expected, concentration-dependently inhibited the maximal neurotoxicity produced by NMDA. The potentiating effect of spermidine observed at nontoxic concentrations of NMDA was not altered by ethanol evidenced by the fact that the EC(50) value for spermidine was not significantly changed in the presence of ethanol. This suggests that ethanol and spermidine produce their effects by acting at different sites within the NMDA receptor complex. In contrast, the inhibitory effect of ethanol on the maximally neurotoxic action of NMDA was significantly reduced by spermidine in a concentration-dependent manner, suggesting that the spermidine enhancement of NMDA receptor function in this situation is more potent and is able mask the inhibitory action of ethanol on other sites within the NMDA receptor.
Cebere
Aleta
A
Department of Clinical Neuroscience, Division of Drug Dependence Research, Karolinska Institutet, 17176 Stockholm, Sweden.
Cebers
Gvido
G
Wägner
Anna
A
Liljequist
Sture
S
D000704:Analysis of Variance; D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002531:Cerebellum / Q000166:cytology / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D000431:Ethanol / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors* / Q000633:toxicity; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018091:Receptors, AMPA / Q000187:drug effects; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects* / Q000502:physiology; D013095:Spermidine / Q000494:pharmacology*
D010880:Piperidines; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; D000431:Ethanol; D016202:N-Methylaspartate; C010739:ifenprodil; D013095:Spermidine; C058083:eliprodil